Top compounds associated with response to LHFPL3


Feature Type Standardized
Nominal ANOVA
mRNA EHT 1864 GDSC1000 pan-cancer AAC 0.066 0.06
mRNA oligomycin a CTRPv2 pan-cancer AAC 0.067 0.06
mRNA CEP-701 GDSC1000 pan-cancer AAC -0.063 0.06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.06
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC 0.097 0.06
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.061 0.06
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.06
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.068 0.06
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.06
Download CSV